Materials 2011, 4(6), 1117-1131; doi:10.3390/ma4061117
Article

Teriparatide Therapy as an Adjuvant for Tissue Engineering and Integration of Biomaterials

1 The Center for Musculoskeletal Research, University of Rochester, Rochester, NY 14623, USA 2 Department of Orthopaedics, University of Rochester, Rochester, NY 14623, USA
* Author to whom correspondence should be addressed.
Received: 4 May 2011; in revised form: 8 June 2011 / Accepted: 14 June 2011 / Published: 15 June 2011
(This article belongs to the Special Issue Advances in Biomaterials 2011)
PDF Full-text Download PDF Full-Text [280 KB, Updated Version, uploaded 20 June 2011 13:59 CEST]
The original version is still available [414 KB, uploaded 15 June 2011 11:22 CEST]
Abstract: Critically sized large bone defects commonly result from trauma, radical tumor resections or infections. Currently, massive allografting remain as the clinical standard to treat these critical defects. Unfortunately, allograft healing is limited by the lack of osteogenesis and bio-integration of the graft to the host bone. Based on its widely studied anabolic effects on the bone, we have proposed that teriparatide [recombinant parathyroid hormone (PTH1–34)] could be an effective adjuvant for massive allograft healing. In support of this theory, here we review studies that have demonstrated that intermittent PTH1–34 treatment enhances and accelerates the skeletal repair process via a number of mechanisms including: effects on mesenchymal stem cells (MSC), angiogenesis, chondrogenesis, bone formation and remodeling. We also review the current literature on the effects of PTH1–34 therapy on bone healing, and discuss this drug’s long term potential as an adjuvant for endogenous tissue engineering.
Keywords: Parathyroid Hormone (PTH); teriparatide; osseointegration; bio-integration; fracture healing; non-union; allograft repair; biomaterials

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Dhillon, R.S.; Schwarz, E.M. Teriparatide Therapy as an Adjuvant for Tissue Engineering and Integration of Biomaterials. Materials 2011, 4, 1117-1131.

AMA Style

Dhillon RS, Schwarz EM. Teriparatide Therapy as an Adjuvant for Tissue Engineering and Integration of Biomaterials. Materials. 2011; 4(6):1117-1131.

Chicago/Turabian Style

Dhillon, Robinder S.; Schwarz, Edward M. 2011. "Teriparatide Therapy as an Adjuvant for Tissue Engineering and Integration of Biomaterials." Materials 4, no. 6: 1117-1131.

Materials EISSN 1996-1944 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert